Aurora Cannabis Inc. (ACB)
Stock analysis · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Aurora Cannabis Inc. (ACB) is a publicly traded company in the Healthcare sector. Latest price: $4.08. Market cap $258.31M. Trailing PE -2.95. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Aurora Cannabis Inc.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive…
Valuation
| P/E (TTM) | -2.95× |
|---|---|
| P/S (TTM) | 1.24× |
| P/B | 0.67× |
| PEG | 0.03× |
| P/FCF (TTM) | -7.08× |
| EV / EBITDA | -3.96× |
| EV / Sales | 0.91× |
| Earnings Yield | -31.50% |
| Free Cash Flow Yield | -14.13% |
Fundamentals
| Enterprise Value | $265.08M |
|---|---|
| Revenue (TTM) | $290.25M |
| Net Income (TTM) | -$113.66M |
| Free Cash Flow (TTM) | -$45.91M |
| Net Debt | -$95.75M |
| Working Capital | $320.16M |
| Gross Margin | 32.08% |
| Operating Margin | -29.66% |
| Net Margin | -38.15% |
| Return on Equity | -21.00% |
| Return on Invested Capital | -15.55% |
Peers
Recent News
- Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
- ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus
- Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-th…
- Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over
- Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
Related
Browse more tickers: sitemap